Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Q1 2021 Financials /Operational update
View:
Comment by Northerencents on May 17, 2021 7:45am
Ugh wrong way 
Comment by okletsmakemoney on May 17, 2021 7:45am
Any thoughts?
Comment by Positivelive1 on May 17, 2021 7:58am
Loss of $2.5 million a month or $7.3 a quarter! Terrible!
Comment by CashCow23 on May 17, 2021 8:11am
Seems like you are terrible at understanding accounting. The results are fine, covid testing is a nice side business that seems to cover their operating costs. They need to close the clinic acquisition and start showing progress with cancer testing.   
Comment by Positivelive1 on May 17, 2021 8:24am
I think I understand the numbers- go ahead and indulge! 
Comment by SAGDollar on May 17, 2021 8:27am
The way things are going there's gonna be more financing to come.. Glad I hit the sell button above a dollar. Balance sheets and net loss is pretty brutal. No where near cash flow positive but I guess thats expected when launching Aristotle and such. I know it's crazy to say but I could see this being sub 50 cents... It will bounce back but I don't think quite yet.
Comment by LithLover on May 17, 2021 11:28am
Cash, beginning of period $6,597,187 Cash, end of period $6,443,401 Net decrease in cash during the period ($153,786) Maybe you need to rethink what cashflow positive means.   And still with $7 million in the bank.  So no, they do not need financing. Any additional financing would be for another acquistion not for operations.  
Comment by Dizzy76 on May 17, 2021 11:31am
This post has been removed in accordance with Community Policy
Comment by LithLover on May 17, 2021 11:38am
It's called bashers are worried.  Company is basically cash flow positive. Operations are being funded almost entirely by revenue from Covid without even touching the bank account which holds a war chest for Aristotle.  The deal with Care Oncology (nice to see them on the call) will highlight Aristotle and with Covid restrictions being lifted, cancer detection and testing will ...more  
Comment by Liked2Think on May 17, 2021 11:47am
This post has been removed in accordance with Community Policy
Comment by Mykndrsn on May 17, 2021 11:53am
This post has been removed in accordance with Community Policy
Comment by LithLover on May 17, 2021 11:53am
This post has been removed in accordance with Community Policy
Comment by Liked2Think on May 17, 2021 12:12pm
This post has been removed in accordance with Community Policy
Comment by Mykndrsn on May 17, 2021 12:15pm
This post has been removed in accordance with Community Policy
Comment by LithLover on May 17, 2021 6:18pm
Basically break even for the quarter and nearly cash flow positive.  $7 million in the bank.  Show me another biotech with this low of a market cap in that solid of a position    
Comment by kodiakup on May 17, 2021 8:59pm
- I don't know where you see 7 million in banks when they have 0.08 / loss shares ...for the last quarter..... Financial Overview   For the fiscal year ended 31 December 2020,StageZero Life Sciences Ltd revenues increased from $139Kto $4.2M. Net loss increased 97% to $6.9M. Revenues reflectan increase in demand for the Company's ...more  
Comment by LithLover on May 17, 2021 9:14pm
Read the financials out on Sedar shows start and ending cash position. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities